Hospitals vs. research labs: who's driving tularemia preparedness?
Hospitals are the largest end‑user segment — they diagnose and treat tularemia cases. But research institutions are the fastest‑growing. The tularemia market research study shows that research labs are growing at over 5% CAGR, driven by government funding for biodefense. Why? Because tularemia is a potential bioweapon, and we need better vaccines and rapid diagnostics. What's...
0 Comments 0 Shares 3 Views 0 Reviews